Get the Stockscreener App
151.29
2.43%
3.90
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $151.29, with a volume of 523.95K.
It is up +2.43% in the last 24 hours and up +8.74% over the past month.
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$147.39
Open:
$147.7
24h Volume:
523.95K
Relative Volume:
0.79
Market Cap:
$7.97B
Revenue:
$1.98B
Net Income/Loss:
$79.10M
P/E Ratio:
71.03
EPS:
2.13
Net Cash Flow:
$51.20M
1W Performance:
+7.03%
1M Performance:
+8.74%
6M Performance:
+10.20%
1Y Performance:
+83.48%
1-Day Range:
$147.48
$151.50
1-Week Range:
$139.43
$151.50
52-Week Range:
$75.36
$153.93
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Exploring Analyst Estimates for Masimo (MASI) Q3 Earnings, Beyond Revenue and EPS - Yahoo Finance
Masimo (MASI): A Promising Medical Stock with Growth Potential - Insider Monkey
IP Forecast: Another Apple Watch Trial Kicks Off In California - Law360
Masimo Sues Ex-CEO Over 'Unprecedented' $450M Demand - Law360
Roubaix Capital LLC Has $4.54 Million Stock Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
Masimo Terminates Kiani’s Employment; Files Lawsuit Alleging He Violated Securities Law - Strata-gee.com
Masimo Corp CEO Joe Kiani terminated, firm reaffirms guidance By Investing.com - Investing.com South Africa
See Why Apple’s Patent Win is Actually a Victory for Masimo - Strata-gee.com
Masimo Corp CEO Joe Kiani terminated, firm reaffirms guidance - Investing.com
Masimo (MASI) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion – Company AnnouncementFT.com - Financial Times
Masimo Sues Founder Over Alleged 'Empty Voting' Scheme - Law360
Apple wins $250 from Masimo in watch patent trial - Yahoo Finance
Masimo Sues Founder Over 'Empty Voting' Against Politan Takeover - Bloomberg Law
Apple Wins $250 in Smartwatch Patent Case Against Masimo - iPhone in Canada
Apple Secures Victory In Masimo Patent Dispute With Token Damages Of $250 - MSN
Here's Why You Should Add Masimo Stock to Your Portfolio Now - MSN
Apple wins $250 US jury verdict in patent case over Masimo smartwatches - Reuters
Jury awards Apple $250 in design patent lawsuit against Masimo - Yahoo Finance
Masimo Claims Victory over Apple after Verdict - Orange County Business Journal
Apple Wins $250, But Little Else, at Trial on Watch Patents (2) - Bloomberg Law
BREAKING: Masimo Beats Most Apple Claims In Smart Watch IP Trial - Law360
Raymond James & Associates Cuts Stock Position in Masimo Co. (NASDAQ:MASI) - MarketBeat
Omitting Engineers in Design Patent Applications is Timeless - JD Supra
Masimo Expands Board with Two New Appointments - Strata-gee.com
Apple Tells Del. Jury It Wants Smartwatch Infringing To Stop - Law360
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
MASI (Masimo) Growth Rank : 9 (As of Oct. 19, 2024) - GuruFocus.com
Piper Sandler maintains overweight on Masimo By Investing.com - Investing.com Australia
Masimo adds two new board members following Politan victory - Mass Device
Masimo Appoints Two New Board Members Following Kiani Resignation - Orange County Business Journal
Piper Sandler maintains overweight on Masimo - Investing.com
Masimo expands board with two new directors - Investing.com
Why Masimo (MASI) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Masimo Corporation: Expansion into Consumer Health Products & Other Major Drivers - Smartkarma
Masimo price target raised to $170 from $166 at BTIG - Yahoo Finance
Masimo (NASDAQ:MASI) Price Target Raised to $170.00 at BTIG Research - MarketBeat
Apple Watch Patents Dodge Ax As Masimo Jury Trial Nears - Law360
Is Masimo Corporation (NASDAQ:MASI) The Top Stock With Improving Technical Ratings According To Piper Sandler? - Insider Monkey
Two Apple Watch Patents Survive Masimo Challenge Ahead of Trial - Bloomberg Law
Masimo Corp maintains stock target amid AAPL legal update - Investing.com
The United States Patient Monitoring Accessories Market Size & Outlook, 2027 - Grand View Research
Split Decision: A Masimo Win and an Apple Win in High Stakes Legal War - Strata-gee.com
Apple Loses Bid For Jury Trial In Masimo Trade Secrets Fight - Law360
Apple Beats Masimo Unenforceability Claim as Patent Trial Looms - Bloomberg Law
Apple Beats Masimo's Allegations Of Misleading USPTO - Law360
SG Americas Securities LLC Purchases Shares of 28,967 Masimo Co. (NASDAQ:MASI) - MarketBeat
Squarepoint Ops LLC Purchases New Shares in Masimo Co. (NASDAQ:MASI) - MarketBeat
Sei Investments Co. Has $2.97 Million Stock Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
Apple Loses Patent In Fight With Masimo At PTAB - Law360
Pulse Oximeter Market Size to Reach USD 4.9 Billion By 2033, at 7.0% CAGR: Insights by Dimension Market Research - GlobeNewswire Inc.
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):